- Financial records made public show the CEO of biotech company Moderna last year earned roughly $393 million from stock options he exercised and got a 50% raise.
-
CEO Stephane Bancel received $1.5 million in 2022, an increase of 50% from the previous year, and Moderna increased his target cash bonus, according to securities and exchange commission filing filed in March.
- The National Institutes of Health gave $1.7 billion in taxpayer funding to Moderna to develop the COVID vaccine, putting the CEO’s salary and stock options under scrutiny.
- After the Securities an Exchange Commission report was published, Bancel said he and his wife generated $393 million from the sale of stock options and they donated $176 million in after-tax proceeds to charity in 2022.
Trending
CEO Of COVID-Vax Making Moderna Last Year Received $4M In Stock Options, 50% Raise
MODERNA CEO in '22 Got $4M In Stock Options, 50% Raise
A Jackson, Miss., resident receives a Moderna COVID-19 booster shot from a Jackson-Hinds Comprehensive Health Center nurse, at a vaccination station next to Jackson State University in Jackson, Miss., Tuesday, Dec. 7, 2021. More than 1,419,000 people have now been fully vaccinated against COVID-19 in Mississippi, and according to the Mississippi State Department of Health, most COVID-19 cases, hospitalizations and deaths are now among unvaccinated Mississippians. (AP Photo/Rogelio V. Solis)
